BKYI - Company ID 0001019034
The table below shows BIO KEY INTERNATIONAL INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$358.00K | -$835.31K | $297.08K | -$1.93M | -$1.43M | -$3.20M |
| Capital expenditure | $0.00 | $4.57K | $1.87K | $0.00 | $4.46K | $13.31K |
| Investing cash flow | $0.00 | -$4.57K | -$1.87K | $0.00 | -$545.04K | -$13.31K |
| Dividends paid | - | - | - |
BIO KEY INTERNATIONAL INC reported operating cash flow of -$4.67M for fiscal year 2025. That is down 60.2% from -$2.91M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$4.45M (FY 2016) to -$4.67M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$38.18K | $3.53M | -$53.89K | -$34.29K | $0.00 | -$252.71K |